Effects of aclidinium bromide in a cigarette smoke-exposed guinea pig model of chronic obstructive pulmonary disease

American Journal of Respiratory Cell and Molecular Biology

Volumn 50, Issue 2, 2014, Pages 337-346

  Domínguez Fandos, David ^a   Ferrer, Elisabet ^a   Puig Pey, Raquel ^a   Carreño, Cristina ^b   Prats, Neus ^b   Aparici, Mònica ^b   Musri, Melina Mara ^a   Gavaldà, Amadeu ^b   Peinado, Víctor I ^a,c   Miralpeix, Montserrat ^b   Barberà, Joan A ^a,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Almirall SA RandD Center ^*  (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Acetylcholine pharmacology; Airway resistance; Emphysema; Inflammation; Muscarinic antagonists

Indexed keywords

ACLIDINIUM BROMIDE; CIGARETTE SMOKE; MUCIN 5AC;

AIRWAY REMODELING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY PLETHYSMOGRAPHY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; COUGHING; EOSINOPHIL; GUINEA PIG; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG DEVELOPMENT; LUNG FUNCTION; MALE; NEUTROPHIL; NEUTROPHILIA; NONHUMAN; SMOOTH MUSCLE;

AIRWAY REMODELING; ANIMALS; DISEASE MODELS, ANIMAL; GUINEA PIGS; INFLAMMATION; LUNG; MALE; MUSCARINIC ANTAGONISTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKE; TOBACCO; TROPANES;

EID: 84893318907     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2013-0117OC     Document Type: Article

References (51)

1. Vestbo J, Hurd SS, Agust́i AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-365.
2. Karner C, Chong J, Poole P. Tiotropium versus placebo for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012;7:CD009285.
3. Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP; UPLIFT Investigators. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet 2009;374:1171-1178.
4. Bateman ED, Rennard S, Barnes PJ, Dicpinigaitis PV, Gosens R, Gross NJ, Nadel JA, Pfeifer M, Racké K, Rabe KF, et al. Alternative mechanisms for tiotropium. Pulm Pharmacol Ther 2009;22:533-542.
5. Gosens R, Rieks D, Meurs H, Ninaber DK, Rabe KF, Nanninga J, Kolahian S, Halayko AJ, Hiemstra PS, Zuyderduyn S. Muscarinic M3 receptor stimulation increases cigarette smoke-induced IL-8 secretion by human airway smooth muscle cells. Eur Respir J 2009;34:1436-1443.
6. Profita M, Bonanno A, Montalbano AM, Ferraro M, Siena L, Bruno A, Girbino S, Albano GD, Casarosa P, Pieper MP, et al. Cigarette smoke extract activates human bronchial epithelial cells affecting nonneuronal cholinergic system signalling in vitro. Life Sci 2011;89:36-43.
7. Suzaki I, Asano K, Shikama Y, Hamasaki T, Kanei A, Suzaki H. Suppression of IL-8 production from airway cells by tiotropium bromide in vitro. Int J Chron Obstruct Pulmon Dis 2011;6:439-448.
8. Gosens R, Zaagsma J, Meurs H, Halayko AJ. Muscarinic receptor signaling in the pathophysiology of asthma and COPD. Respir Res 2006;7:73.
9. Gosens R, Nelemans SA, Grootte Bromhaar MM, McKay S, Zaagsma J, Meurs H. Muscarinic M3-receptors mediate cholinergic synergism of mitogenesis in airway smooth muscle. Am J Respir Cell Mol Biol 2003; 28:257-262.
10. Krymskaya VP, Orsini MJ, Eszterhas AJ, Brodbeck KC, Benovic JL, Panettieri RA Jr, Penn RB. Mechanisms of proliferation synergy by receptor tyrosine kinase and G protein-coupled receptor activation in human airway smooth muscle. Am J Respir Cell Mol Biol 2000;23:546-554.
11. Wollin L, Pieper MP. Tiotropium bromide exerts anti-inflammatory activity in a cigarette smoke mouse model of COPD. Pulm Pharmacol Ther 2010;23:345-354.
12. Damera G, Jiang M, Zhao H, Fogle HW, Jester WF, Freire J, Panettieri RA Jr. Aclidinium bromide abrogates allergen-induced hyperresponsiveness and reduces eosinophilia in murine model of airway inflammation. Eur J Pharmacol 2010;649:349-353.
13. Bos IS, Gosens R, Zuidhof AB, Schaafsma D, Halayko AJ, Meurs H, Zaagsma J. Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison. Eur Respir J 2007;30: 653-661.
14. Buels KS, Jacoby DB, Fryer AD. Non-bronchodilating mechanisms of tiotropium prevent airway hyperreactivity in a guinea-pig model of allergic asthma. Br J Pharmacol 2012;165:1501-1514.
15. Gosens R, Bos IS, Zaagsma J, Meurs H. Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. Am J Respir Crit Care Med 2005;171: 1096-1102.
16. Ohta S, Oda N, Yokoe T, Tanaka A, Yamamoto Y, Watanabe Y, Minoguchi K, Ohnishi T, Hirose T, Nagase H, et al. Effect of tiotropium bromide on airway inflammation and remodelling in a mouse model of asthma. Clin Exp Allergy 2010;40: 1266-1275.
17. Pera T, Zuidhof A, Valadas J, Smit M, Schoemaker RG, Gosens R, Maarsingh H, Zaagsma J, Meurs H. Tiotropium inhibits pulmonary inflammation and remodelling in a guinea pig model of COPD. Eur Respir J 2011;38:789-796.
18. Wright JL, Churg A. Animal models of cigarette smoke-induced COPD. Chest 2002; 122(6 Suppl)301S-306S.
19. Wright JL, Churg A. A model of tobacco smoke-induced airflow obstruction in the guinea pig. Chest 2002; 121(5 Suppl)188S-191S.
20. Gavaldà A, Miralpeix M, Ramos I, Otal R, Carreño C, Viñals M, Domé nech T, Carcasona C, Reyes B, Vilella D, et al. Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile. J Pharmacol Exp Ther 2009;331:740-751.
21. European Medicines Agency. Eklira Genuair and Bretaris Genuair (aclidinium bromide) [Internet]. London: European Medicines Agency; c2012 [updated 2013 Aug 8; accessed 2013 Jul 29]. Available from: http://www.ema. europa.eu/ema/index.jsp? curl=pages/medicines/human/medicines/002211/human-med- 001571.jsp&mid=WC0b01ac058001d1244
22. U.S. Food and Drug Administration. Turdoza Pressair (aclidinium bromide) [Internet]. Silver Spring, MD: U.S. Food and Drug Administration; c2012 [accessed 2013 Jul 29]. Available from: http://www.accessdata.fda.gov/scripts/ cder/drugsatfda/index.cfm? fuseaction=Search.DrugDetailss
23. Maltais F, Celli B, Casaburi R, Porszasz J, Jarreta D, Seoane B, Caracta C. Aclidinium bromide improves exercise endurance and lung hyperinflation in patients with moderate to severe COPD. Respir Med 2011;105:580-587.
24. Fuhr R, Magnussen H, Sarem K, Llovera AR, Kirsten AM, Falqué s M, Caracta CF, Garcia Gil E. Efficacy of aclidinium bromide 400 mg twice daily compared with placebo and tiotropium in patients with moderate to severe COPD. Chest 2012;141:745-752.
25. Kerwin EM, D'Urzo AD, Gelb AF, Lakkis H, Garcia Gil E, Caracta CF; ACCORD I Study Investigators. Efficacy and safety of a 12-week treatment with twice-daily aclidinium bromide in COPD patients (ACCORD COPD I). COPD 2012;9:90-101.
26. Jones PW, Singh D, Bateman ED, Agusti A, Lamarca R, de Miquel G, Segarra R, Caracta C, Garcia Gil E. Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study. Eur Respir J 2012;40:830-836.
27. Milara J, Serrano A, Peiró T, Gavaldà A, Miralpeix M, Morcillo EJ, Cortijo J. Aclidinium inhibits human lung fibroblast to myofibroblast transition. Thorax 2012;67:229-237.
28. Doḿinguez-Fandos D, Peinado VI, Puig-Pey R, Ferrer E, Musri MM, Raḿirez J, Barberà JA. Pulmonary inflammatory reaction and structural changes induced by cigarette smoke exposure in the guinea pig. COPD 2012;9:473-484.
29. Ferrer E, Peinado VI, D́iez M, Carrasco JL, Musri MM, Mart́inez A, Rodŕiguez-Roisin R, Barberà JA. Effects of cigarette smoke on endothelial function of pulmonary arteries in the guinea pig. Respir Res 2009;10:76.
30. Doḿinguez-Fandos D, Puig-Pey R, Ferrer E, Carreño C, Aparici M, Beleta J, Prats N, Miralpeix M, Gavaldà A, Peinado VI, et al. Effects of aclidinium bromide on airway remodeling in guinea pigs exposed to cigarette smoke for 6 months [abstract]. Presented at the American Thoracic Society International Conference. May 13-18, 2011, Denver, CO.
31. Ferrer E, Doḿinguez-Fandos D, Puig-Pey R, Carreño C, Aparici M, Beleta J, Prats N, Miralpeix M, Gavaldà A, Peinado VI, et al. Effects of aclidinium bromide on respiratory function in guinea pigs exposed to cigarette smoke for 6 months [abstract]. Presented at the American Thoracic Society International Conference. May 13-18, 2011, Denver, CO.
32. Lomask M. Further exploration of the Penh parameter. Exp Toxicol Pathol 2006;57:13-20.
33. Lewis CA, Ambrose C, Banner K, Battram C, Butler K, Giddings J, Mok J, Nasra J, Winny C, Poll C. Animal models of cough: literature review and presentation of a novel cigarette smoke-enhanced cough model in the guinea-pig. Pulm Pharmacol Ther 2007;20:325-333.
34. James AL, Hogg JC, Dunn LA, Paré PD. The use of the internal perimeter to compare airway size and to calculate smooth muscle shortening. Am Rev Respir Dis 1988;138:136-139.
35. Olea E, Ferrer E, Prieto-Lloret J, Gonzalez-Martin C, Vega-Agapito V, Gonzalez-Obeso E, Agapito T, Peinado V, Obeso A, Barbera JA, et al. Effects of cigarette smoke and chronic hypoxia on airways remodeling and resistance: clinical significance. Respir Physiol Neurobiol 2011;179:305-313.
36. Wright JL, Postma DS, Kerstjens HA, Timens W, Whittaker P, Churg A. Airway remodeling in the smoke exposed guinea pig model. Inhal Toxicol 2007;19:915-923.
37. Gwilt CR, Donnelly LE, Rogers DF. The non-neuronal cholinergic system in the airways: an unappreciated regulatory role in pulmonary inflammation? Pharmacol Ther 2007;115:208-222.
38. Roffel AF, Elzinga CR, Zaagsma J. Muscarinic M3 receptors mediate contraction of human central and peripheral airway smooth muscle. Pulm Pharmacol 1990;3:47-51.
39. Wessler I, Kirkpatrick CJ. Acetylcholine beyond neurons: the nonneuronal cholinergic system in humans. Br J Pharmacol 2008;154: 1558-1571.
40. Perng DW, Tao CW, Su KC, Tsai CC, Liu LY, Lee YC. Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD. Eur Respir J 2009;33:778-784.
41. Wen Y, Reid DW, Zhang D, Ward C, Wood-Baker R, Walters EH. Assessment of airway inflammation using sputum, BAL, and endobronchial biopsies in current and ex-smokers with established COPD. Int J Chron Obstruct Pulmon Dis 2010;5: 327-334.
42. Pieper MP, Chaudhary NI, Park JE. Acetylcholine-induced proliferation of fibroblasts and myofibroblasts in vitro is inhibited by tiotropium bromide. Life Sci 2007;80:2270-2273.
43. Gosens R, Bromhaar MM, Tonkes A, Schaafsma D, Zaagsma J, Nelemans SA, Meurs H. Muscarinic M(3) receptor-dependent regulation of airway smooth muscle contractile phenotype. Br J Pharmacol 2004;141:943-950.
44. Richens TR, Linderman DJ, Horstmann SA, Lambert C, Xiao YQ, Keith RL, Boé DM, Morimoto K, Bowler RP, Day BJ, et al. Cigarette smoke impairs clearance of apoptotic cells through oxidantdependent activation of RhoA. Am J Respir Crit Care Med 2009; 179:1011-1021.
45. Churg A, Sin DD, Wright JL. Everything prevents emphysema: are animal models of cigarette smoke-induced chronic obstructive pulmonary disease any use? Am J Respir Cell Mol Biol 2011;45: 1111-1115.
46. Saetta M, Turato G, Baraldo S, Zanin A, Braccioni F, Mapp CE, Maestrelli P, Cavallesco G, Papi A, Fabbri LM. Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation. Am J Respir Crit Care Med 2000;161: 1016-1021.
47. Innes AL, Woodruff PG, Ferrando RE, Donnelly S, Dolganov GM, Lazarus SC, Fahy JV. Epithelial mucin stores are increased in the large airways of smokers with airflow obstruction. Chest 2006;130: 1102-1108.
48. Cortijo J, Mata M, Milara J, Donet E, Gavaldà A, Miralpeix M, Morcillo EJ. Aclidinium inhibits cholinergic and tobacco smoke-induced MUC5AC in human airways. Eur Respir J 2011;37:244-254.
49. Caramori G, Di Gregorio C, Carlstedt I, Casolari P, Guzzinati I, Adcock IM, Barnes PJ, Ciaccia A, Cavallesco G, Chung KF, et al. Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease. Histopathology 2004;45:477-484.
50. Ardite E, Peinado VI, Rabinovich RA, Ferná ndez-Checa JC, Roca J, Barberà JA. Systemic effects of cigarette smoke exposure in the guinea pig. Respir Med 2006;100:1186-1194.
51. Caramori G, Casolari P, Di Gregorio C, Saetta M, Baraldo S, Boschetto P, Ito K, Fabbri LM, Barnes PJ, Adcock IM, et al. MUC5AC expression is increased in bronchial submucosal glands of stable COPD patients. Histopathology 2009;55:321-331.